Back to Search

BRAD SPAGNOLO, MD

MD

Ophthalmology Physician

NPI: 1689679425IndividualAccepts Medicare

Specialties, Licenses & Credentials

Ophthalmology PhysicianPrimary

Ophthalmology

Code: 207W00000X

D0056098(MD)

CMS Specialties

PrimaryOPHTHALMOLOGY

Education

TEMPLE UNIVERSITY SCHOOL OF MEDICINE

Class of 1995

Research & Publications (20)

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
PMID 18069089·Peptides·2008
7-preclinical
Cutting balloon angioplasty in percutaneous carotid interventions.
PMID 19090627·J Endovasc Ther·2008
4-observational
Activities of mixed NOP and mu-opioid receptor ligands.
PMID 18059322·Br J Pharmacol·2008
7-preclinical
Epidural analgesia in children: planning, organization and development of a new program.
PMID 17952030·Minerva Anestesiol·2007
8-other
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
PMID 17532097·Peptides·2007
7-preclinical
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
PMID 17490886·Bioorg Med Chem·2007
7-preclinical
Mean escape time in a system with stochastic volatility.
PMID 17358223·Phys Rev E Stat Nonlin Soft Matter Phys·2007
8-other
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
PMID 17329552·J Pharmacol Exp Ther·2007
7-preclinical
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
PMID 17329551·J Pharmacol Exp Ther·2007
7-preclinical
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
PMID 16963157·Peptides·2006
7-preclinical
Co-occurrence of resonant activation and noise-enhanced stability in a model of cancer growth in the presence of immune response.
PMID 17155093·Phys Rev E Stat Nonlin Soft Matter Phys·2006
7-preclinical
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
PMID 16682024·Eur J Pharmacol·2006
7-preclinical
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist.
PMID 16202610·Bioorg Med Chem·2006
7-preclinical
Acceleration of diffusion in randomly switching potential with supersymmetry.
PMID 16383359·Phys Rev E Stat Nonlin Soft Matter Phys·2005
8-other
Signatures of noise-enhanced stability in metastable states.
PMID 16485934·Phys Rev E Stat Nonlin Soft Matter Phys·2005
8-other
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.
PMID 15946194·J Pept Res·2005
7-preclinical
Suppression of timing errors in short overdamped josephson junctions.
PMID 15525111·Phys Rev Lett·2004
8-other
Noise-enhanced stability in fluctuating metastable states.
PMID 15244536·Phys Rev E Stat Nonlin Soft Matter Phys·2004
8-other
Noise-enhanced stability of periodically driven metastable states.
PMID 11580375·Phys Rev E Stat Nonlin Soft Matter Phys·2001
8-other
Linear and nonlinear experimental regimes of stochastic resonance.
PMID 11304228·Phys Rev E Stat Nonlin Soft Matter Phys·2001
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
200 HOSPITAL DR, STE 600
GLEN BURNIE, MD 21061

Location

Practice Location

200 HOSPITAL DR, GLEN BURNIE, MD
(410) 766-3937

Quick Facts

NPI
1689679425
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
31
Publications
20

Are you this provider?

Claim Your Profile